Sarcopenia and critical illness: A deadly combination in the elderly

Journal of Parenteral and Enteral Nutrition

Volumn 39, Issue 3, 2015, Pages 273-281

  Hanna, Joseph S ^a  

^a ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

Author keywords

aging; critical illness; elderly; exercise; frailty; inflammation; malnutrition; sarcopenia

Indexed keywords

AMINO ACID; FREE RADICAL; MITOCHONDRIAL DNA; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR;

ADL DISABILITY; AGED; AGING; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOPHAGY; CHRONIC INFLAMMATION; CONTINUOUS PASSIVE MOVEMENT DEVICE; CRITICAL ILLNESS; DAILY LIFE ACTIVITY; DISABILITY; DNA DAMAGE; ELECTROSTIMULATION THERAPY; EXERCISE; EXHAUSTION; FEEDING APPARATUS; FEMALE; FRAIL ELDERLY; GRIP STRENGTH; HUMAN; IMMOBILITY; LEG FRACTURE; LOCOMOTION; MALE; MALNUTRITION; MEDICAL DEVICE; MUSCLE ATROPHY; MUSCLE CELL; MUSCLE EXCITATION; MUSCLE MASS; MUSCLE METABOLISM; NEUROMUSCULAR ELECTRICAL STIMULATION; NONHUMAN; NURSING HOME PATIENT; NUTRITIONAL ASSESSMENT; NUTRITIONAL STATUS; NUTRITIONAL SUPPORT; PASSIVE MOVEMENT; PATIENT MONITORING; PHYSICAL ACTIVITY; PHYSIOTHERAPY; PRIORITY JOURNAL; PROTEIN DEGRADATION; RAT; SARCOPENIA; SKELETAL MUSCLE; WALKING AID; WEIGHT REDUCTION; COMPLICATION; ENERGY METABOLISM; METABOLIC DISEASES; METABOLISM; MUSCLE DISEASE; PATHOLOGY;

AGED; AGING; CRITICAL ILLNESS; ENERGY METABOLISM; FRAIL ELDERLY; HUMANS; METABOLIC DISEASES; MUSCLE, SKELETAL; MUSCULAR DISEASES; SARCOPENIA; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84924968014     PISSN: 01486071     EISSN: 19412444     Source Type: Journal    
DOI: 10.1177/0148607114567710     Document Type: Article

References (124)

1. Janssen I, Baumgartner RN, Ross R, Rosenberg IH, Roubenoff R. Skeletal muscle cutpoints associated with elevated physical disability risk in older men and women. Am J Epidemiol. 2004 ; 159 (4). 413-421
2. Janssen I, Shepard DS, Katzmarzyk PT, Roubenoff R. The healthcare costs of sarcopenia in the United States. J Am Geriatr Soc. 2004 ; 52 (1). 80-85
3. Fried LP, Tangen CM, Walston J, et al. Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci. 2001 ; 56 (3). M146 - M156
4. Coronado VG, Xu L, Basavaraju SV, et al. Surveillance for traumatic brain injury-related deaths - United States, 1997-2007. Morb Mortal Wkly Rep Surveill Summ. 2011 ; 60 (5). 1-32
5. Sterling DA, O'Connor JA, Bonadies J. Geriatric falls: injury severity is high and disproportionate to mechanism. J Trauma. 2001 ; 50 (1). 116-119
6. Reddy M, Gill SS, Rochon PA. Preventing pressure ulcers: a systematic review. JAMA. 2006 ; 296 (8). 974-984
7. Yablon S, Krotenberg R, Fruhmann K. Clostridium difficile-related disease: evaluation and prevalence among inpatients with diarrhea in two freestanding rehabilitation hospitals. Arch Phys Med Rehabil. 1993 ; 74 (1). 9-13
8. Laffan AM, Bellantoni MF, Greenough WB, Zenilman JM. Burden of Clostridium difficile-associated diarrhea in a long-term care facility. J Am Geriatr Soc. 2006 ; 54 (7). 1068-1073
9. Ensrud KE, Ewing SK, Taylor BC, et al. Comparison of 2 frailty indexes for prediction of falls, disability, fractures, and death in older women. Arch Intern Med. 2008 ; 168 (4). 382-389
10. Woods NF, LaCroix AZ, Gray SL, et al. Frailty: emergence and consequences in women aged 65 and older in the Women's Health Initiative Observational Study. J Am Geriatr Soc. 2005 ; 53 (8). 1321-1330
11. Xue Q-L, Bandeen-Roche K, Varadhan R, Zhou J, Fried LP. Initial manifestations of frailty criteria and the development of frailty phenotype in the Women's Health and Aging Study II. J Gerontol A Biol Sci Med Sci. 2008 ; 63 (9). 984-990
12. Mitnitski AB, Graham JE, Mogilner AJ, Rockwood K. Frailty, fitness and late-life mortality in relation to chronological and biological age. BMC Geriatr. 2002 ; 2: 1
13. Rosenberg IH. Sarcopenia: origins and clinical relevance. J Nutr. 1997 ; 127 (5). 990S - 991S
14. Hughes VA, Frontera WR, Wood M, et al. Longitudinal muscle strength changes in older adults: influence of muscle mass, physical activity, and health. J Gerontol A Biol Sci Med Sci. 2001 ; 56 (5). B209 - B217
15. Baumgartner RN, Koehler KM, Gallagher D, et al. Epidemiology of sarcopenia among the elderly in New Mexico. Am J Epidemiol. 1998 ; 147 (8). 755-763
16. Janssen I, Heymsfield SB, Ross R. Low relative skeletal muscle mass (sarcopenia) in older persons is associated with functional impairment and physical disability. J Am Geriatr Soc. 2002 ; 50 (5). 889-896
17. Newman AB, Kupelian V, Visser M, et al. Sarcopenia: alternative definitions and associations with lower extremity function. J Am Geriatr Soc. 2003 ; 51 (11). 1602-1609
18. Abellan van Kan G. Epidemiology and consequences of sarcopenia. J Nutr Health Aging. 2009 ; 13 (8). 708-712
19. Mitchell WK, Williams J, Atherton P, Larvin M, Lund J, Narici M. Sarcopenia, dynapenia, and the impact of advancing age on human skeletal muscle size and strength; a quantitative review. Front Physiol. 2012 ; 3: 260
20. Song M-Y, Ruts E, Kim J, Janumala I, Heymsfield S, Gallagher D. Sarcopenia and increased adipose tissue infiltration of muscle in elderly African American women. Am J Clin Nutr. 2004 ; 79 (5). 874-880
21. Greising SM, Gransee HM, Mantilla CB, Sieck GC. Systems biology of skeletal muscle: fiber type as an organizing principle. Wiley Interdiscip Rev Syst Biol Med. 2012 ; 4 (5). 457-473
22. Lauretani F, Russo CR, Bandinelli S, et al. Age-associated changes in skeletal muscles and their effect on mobility: an operational diagnosis of sarcopenia. J Appl Physiol. 2003 ; 95 (5). 1851-1860
23. Evans WJ, Paolisso G, Abbatecola AM, et al. Frailty and muscle metabolism dysregulation in the elderly. Biogerontology. 2010 ; 11 (5). 527-536
24. Newman AB, Kupelian V, Visser M, et al. Strength, but not muscle mass, is associated with mortality in the health, aging and body composition study cohort. J Gerontol A Biol Sci Med Sci. 2006 ; 61 (1). 72-77
25. Visser M, Goodpaster BH, Kritchevsky SB, et al. Muscle mass, muscle strength, and muscle fat infiltration as predictors of incident mobility limitations in well-functioning older persons. J Gerontol A Biol Sci Med Sci. 2005 ; 60 (3). 324-333
26. Cruz-Jentoft AJ, Baeyens JP, Bauer JM, et al. Sarcopenia: European consensus on definition and diagnosis: report of the European Working Group on Sarcopenia in Older People. Age Ageing. 2010 ; 39 (4). 412-423
27. Calvani R, Joseph A-M, Adhihetty PJ, et al. Mitochondrial pathways in sarcopenia of aging and disuse muscle atrophy. Biol Chem. 2013 ; 394 (3). 393-414
28. Short KR, Bigelow ML, Kahl J, et al. Decline in skeletal muscle mitochondrial function with aging in humans. Proc Natl Acad Sci U S A. 2005 ; 102 (15). 5618-5623
29. Conley KE, Marcinek DJ, Villarin J. Mitochondrial dysfunction and age. Curr Opin Clin Nutr Metab. Care. 2007 ; 10 (6). 688-692
30. Conley KE, Jubrias SA, Cress ME, Esselman P. Exercise efficiency is reduced by mitochondrial uncoupling in the elderly. Exp Physiol. 2013 ; 98 (3). 768-777
31. Hollenberg M, Yang J, Haight TJ, Tager IB. Longitudinal changes in aerobic capacity: implications for concepts of aging. J Gerontol A Biol Sci Med Sci. 2006 ; 61 (8). 851-858
32. Gouspillou G, Bourdel-Marchasson I, Rouland R, et al. Mitochondrial energetics is impaired in vivo in aged skeletal muscle. Aging Cell. 2014 ; 13 (1). 39-48
33. Siegel MP, Wilbur T, Mathis M, et al. Impaired adaptability of in vivo mitochondrial energetics to acute oxidative insult in aged skeletal muscle. Mech Ageing Dev. 2012 ; 133 (9-10). 620-628
34. Volpi E, Sheffield-Moore M, Rasmussen BB, Wolfe RR. Basal muscle amino acid kinetics and protein synthesis in healthy young and older men. JAMA. 2001 ; 286 (10). 1206-1212
35. Welle S, Thornton C, Jozefowicz R, Statt M. Myofibrillar protein synthesis in young and old men. Am J Physiol. 1993 ; 264 (5, pt 1). E693 - E698
36. Fujita S, Rasmussen BB, Bell JA, Cadenas JG, Volpi E. Basal muscle intracellular amino acid kinetics in women and men. Am J Physiol Endocrinol Metab. 2007 ; 292 (1). E77 - E83
37. Cuthbertson D, Smith K, Babraj J, et al. Anabolic signaling deficits underlie amino acid resistance of wasting, aging muscle. FASEB J. 2005 ; 19 (3). 422-424
38. Balagopal P, Rooyackers OE, Adey DB, Ades PA, Nair KS. Effects of aging on in vivo synthesis of skeletal muscle myosin heavy-chain and sarcoplasmic protein in humans. Am J Physiol. 1997 ; 273 (4, pt 1). E790 - E800
39. Luff AR. Age-associated changes in the innervation of muscle fibers and changes in the mechanical properties of motor units. Ann N Y Acad Sci. 1998 ; 854: 92-101
40. Brunner F, Schmid A, Sheikhzadeh A, Nordin M, Yoon J, Frankel V. Effects of aging on type II muscle fibers: a systematic review of the literature. J Aging Phys Act. 2007 ; 15 (3). 336-348
41. Taylor AD, Humphries B, Smith P, Bronks R. Electrophoretic separation of myosin heavy chain isoforms in the human m. vastus lateralis: references to reproducibility and relationships with force, electromechanical delay, fibre conduction velocity, endurance and electromyography. Arch Physiol Biochem. 1997 ; 105 (1). 10-18
42. Aagaard P, Andersen JL. Correlation between contractile strength and myosin heavy chain isoform composition in human skeletal muscle. Med Sci Sports Exerc. 1998 ; 30 (8). 1217-1222
43. Pearson SJ, Cobbold M, Orrell RW, Harridge SDR. Power output and muscle myosin heavy chain composition in young and elderly men. Med Sci Sports Exerc. 2006 ; 38 (9). 1601-1607
44. Nilwik R, Snijders T, Leenders M, et al. The decline in skeletal muscle mass with aging is mainly attributed to a reduction in type II muscle fiber size. Exp Gerontol. 2013 ; 48 (5). 492-498
45. Fong Y, Moldawer LL, Marano M, et al. Cachectin/TNF or IL-1 alpha induces cachexia with redistribution of body proteins. Am J Physiol. 1989 ; 256 (3, pt 2). R659 - R665
46. Zoico E, Roubenoff R. The role of cytokines in regulating protein metabolism and muscle function. Nutr Rev. 2002 ; 60 (2). 39-51
47. Barbaro F, Carpagnano GE, Spanevello A, Cagnazzo MG, Barnes PJ. Inflammation, oxidative stress and systemic effects in mild chronic obstructive pulmonary disease. Int J Immunopathol Pharmacol. 2007 ; 20 (4). 753-763
48. Pedersen BK, Febbraio MA. Muscle as an endocrine organ: focus on muscle-derived interleukin-6. Physiol Rev. 2008 ; 88 (4). 1379-1406
49. Mariani E, Cattini L, Neri S, et al. Simultaneous evaluation of circulating chemokine and cytokine profiles in elderly subjects by multiplex technology: relationship with zinc status. Biogerontology. 2006 ; 7 (5-6). 449-459
50. Wei J, Xu H, Davies JL, Hemmings GP. Increase of plasma IL-6 concentration with age in healthy subjects. Life Sci. 1992 ; 51 (25). 1953-1956
51. Bruunsgaard H, Andersen-Ranberg K, Hjelmborg Jv, Pedersen BK, Jeune B. Elevated levels of tumor necrosis factor alpha and mortality in centenarians. Am J Med. 2003 ; 115 (4). 278-283
52. Michaud M, Balardy L, Moulis G, et al. Proinflammatory cytokines, aging, and age-related diseases. J Am Med Dir Assoc. 2013 ; 14 (12). 877-882
53. Penninx BWJH, Kritchevsky SB, Newman AB, et al. Inflammatory markers and incident mobility limitation in the elderly. J Am Geriatr Soc. 2004 ; 52 (7). 1105-1113
54. Tzanavari T, Giannogonas P, Karalis KP. TNF-alpha and obesity. Curr Dir Autoimmun. 2010 ; 11: 145-156
55. Lang CH, Frost RA, Nairn AC, MacLean DA, Vary TC. TNF-alpha impairs heart and skeletal muscle protein synthesis by altering translation initiation. Am J Physiol Endocrinol Metab. 2002 ; 282 (2). E336 - E347
56. Lang CH, Frost RA. Sepsis-induced suppression of skeletal muscle translation initiation mediated by tumor necrosis factor alpha. Metabolism. 2007 ; 56 (1). 49-57
57. Ma XM, Blenis J. Molecular mechanisms of mTOR-mediated translational control. Nat Rev Mol Cell Biol. 2009 ; 10 (5). 307-318
58. Dickinson JM, Fry CS, Drummond MJ, et al. Mammalian target of rapamycin complex 1 activation is required for the stimulation of human skeletal muscle protein synthesis by essential amino acids. J Nutr. 2011 ; 141 (5). 856-862
59. Colbert LH, Visser M, Simonsick EM, et al. Physical activity, exercise, and inflammatory markers in older adults: findings from the Health, Aging and Body Composition Study. J Am Geriatr Soc. 2004 ; 52 (7). 1098-1104
60. Reuben DB, Judd-Hamilton L, Harris TB, Seeman TE. The associations between physical activity and inflammatory markers in high-functioning older persons: MacArthur Studies of Successful Aging. J Am Geriatr Soc. 2003 ; 51 (8). 1125-1130
61. Taaffe DR, Harris TB, Ferrucci L, Rowe J, Seeman TE. Cross-sectional and prospective relationships of interleukin-6 and C-reactive protein with physical performance in elderly persons: MacArthur studies of successful aging. J Gerontol A Biol Sci Med Sci. 2000 ; 55 (12). M709 - M715
62. Papanicolaou DA, Wilder RL, Manolagas SC, Chrousos GP. The pathophysiologic roles of interleukin-6 in human disease. Ann Intern Med. 1998 ; 128 (2). 127-137
63. Angus DC, Kelley MA, Schmitz RJ, White A, Popovich J. Caring for the critically ill patient. Current and projected workforce requirements for care of the critically ill and patients with pulmonary disease: can we meet the requirements of an aging population?. JAMA. 2000 ; 284 (21). 2762-2770
64. Puthucheary Z, Harridge S, Hart N. Skeletal muscle dysfunction in critical care: wasting, weakness, and rehabilitation strategies. Crit Care Med. 2010 ; 38 (10). S676 - S682
65. Batt J, dos Santos CC, Cameron JI, Herridge MS. Intensive care unit-acquired weakness: clinical phenotypes and molecular mechanisms. Am J Respir Crit Care Med. 2013 ; 187 (3). 238-246
66. Bagshaw SM, Stelfox HT, McDermid RC, et al. Association between frailty and short- and long-term outcomes among critically ill patients: a multicentre prospective cohort study. CMAJ. 2014 ; 186 (2). E95 - E102
67. Khouli H, Astua A, Dombrowski W, et al. Changes in health-related quality of life and factors predicting long-term outcomes in older adults admitted to intensive care units. Crit Care Med. 2011 ; 39 (4). 731-737
68. Baumgartner RN, Koehler KM, Romero L, Garry PJ. Serum albumin is associated with skeletal muscle in elderly men and women. Am J Clin Nutr. 1996 ; 64 (4). 552-558
69. Corti MC, Guralnik JM, Salive ME, Sorkin JD. Serum albumin level and physical disability as predictors of mortality in older persons. JAMA. 1994 ; 272 (13). 1036-1042
70. Moisey LL, Mourtzakis M, Cotton BA, et al. Skeletal muscle predicts ventilator-free days, ICU-free days, and mortality in elderly ICU patients. Crit Care. 2013 ; 17 (5). R206
71. Wang HE, Shapiro NI, Griffin R, Safford MM, Judd S, Howard G. Chronic medical conditions and risk of sepsis. PLoS ONE. 2012 ; 7 (10). e48307
72. Lipshutz AKM, Gropper MA. Acquired neuromuscular weakness and early mobilization in the intensive care unit. Anesthesiology. 2013 ; 118 (1). 202-215
73. Hoffer LJ, Bistrian BR. Why critically ill patients are protein deprived. JPEN J Parenter Enteral Nutr. 2013 ; 37 (3). 300-309
74. Ramprasad R, Kapoor MC. Nutrition in intensive care. J Anaesthesiol Clin Pharmacol. 2012 ; 28 (1). 1-3
75. Dardaine V, Dequin PF, Ripault H, Constans T, Giniès G. Outcome of older patients requiring ventilatory support in intensive care: impact of nutritional status. J Am Geriatr Soc. 2001 ; 49 (5). 564-570
76. Carré JE, Orban J-C, Re L, et al. Survival in critical illness is associated with early activation of mitochondrial biogenesis. Am J Respir Crit Care Med. 2010 ; 182 (6). 745-751
77. Exline MC, Crouser ED. Mitochondrial dysfunction during sepsis: still more questions than answers. Crit Care Med. 2011 ; 39 (5). 1216-1217
78. Menger MD, Vollmar B. Surgical trauma: hyperinflammation versus immunosuppression?. Langenbecks Arch Surg. 2004 ; 389 (6). 475-484
79. Ramachandran A, Patra S, Balasubramanian KA. Intestinal mitochondrial dysfunction in surgical stress. J Surg Res. 2001 ; 99 (1). 120-128
80. Sullivan DH, Sun S, Walls RC. Protein-energy undernutrition among elderly hospitalized patients: a prospective study. JAMA. 1999 ; 281 (21). 2013-2019
81. Berg JM, Tymoczko JL, Stryer L Biochemistry. New York: W. H. Freeman ; 2002:
82. Cahill GF. Fuel metabolism in starvation. Annu Rev Nutr. 2006 ; 26: 1-22
83. Elia M, Stubbs RJ, Henry CJ. Differences in fat, carbohydrate, and protein metabolism between lean and obese subjects undergoing total starvation. Obes Res. 1999 ; 7 (6). 597-604
84. Finn PF, Dice JF. Proteolytic and lipolytic responses to starvation. Nutrition. 2006 ; 22 (7-8). 830-844
85. Schiaffino S, Dyar KA, Ciciliot S, Blaauw B, Sandri M. Mechanisms regulating skeletal muscle growth and atrophy. FEBS J. 2013 ; 280 (17). 4294-4314
86. McClave SA, Martindale RG, Vanek VW, et al. Guidelines for the provision and assessment of nutrition support therapy in the adult critically ill patient: Society of Critical Care Medicine (SCCM) and American Society for Parenteral and Enteral Nutrition (A.S.P.E.N.). JPEN J Parenter Enter Nutr. 2009 ; 33 (3). 277-316
87. Sobotka L, Schneider SM, Berner YN, et al. ESPEN guidelines on parenteral nutrition: geriatrics. Clin Nutr. 2009 ; 28 (4). 461-466
88. Singer P, Berger MM, Van den Berghe G, et al. ESPEN guidelines on parenteral nutrition: intensive care. Clin Nutr. 2009 ; 28 (4). 387-400
89. Casaer MP, Van den Berghe G. Nutrition in the acute phase of critical illness. N Engl J Med. 2014 ; 370 (13). 1227-1236
90. Gianotti L, Alexander JW, Nelson JL, Fukushima R, Pyles T, Chalk CL. Role of early enteral feeding and acute starvation on postburn bacterial translocation and host defense: prospective, randomized trials. Crit Care Med. 1994 ; 22 (2). 265-272
91. Strack van Schijndel RJM, Weijs PJM, Koopmans RH, Sauerwein HP, Beishuizen A, Girbes ARJ. Optimal nutrition during the period of mechanical ventilation decreases mortality in critically ill, long-term acute female patients: a prospective observational cohort study. Crit Care. 2009 ; 13 (4). R132
92. Weijs PJM, Stapel SN, de Groot SDW, et al. Optimal protein and energy nutrition decreases mortality in mechanically ventilated, critically ill patients: a prospective observational cohort study. JPEN J Parenter Enteral Nutr. 2012 ; 36 (1). 60-68
93. Harris JA, Benedict FG A Biometric Study of Basal Metabolism in Man. Washington, DC: Carnegie Institution of Washington ; 1919:
94. Cerra FB, Benitez MR, Blackburn GL, et al. Applied nutrition in ICU patients: a consensus statement of the American College of Chest Physicians. Chest. 1997 ; 111 (3). 769-778
95. Frankenfield DC, Coleman A, Alam S, Cooney RN. Analysis of estimation methods for resting metabolic rate in critically ill adults. JPEN J Parenter Enteral Nutr. 2009 ; 33 (1). 27-36
96. Paddon-Jones D, Sheffield-Moore M, Zhang X-J, et al. Amino acid ingestion improves muscle protein synthesis in the young and elderly. Am J Physiol Endocrinol Metab. 2004 ; 286 (3). E321 - E328
97. Katsanos CS, Kobayashi H, Sheffield-Moore M, Aarsland A, Wolfe RR. A high proportion of leucine is required for optimal stimulation of the rate of muscle protein synthesis by essential amino acids in the elderly. Am J Physiol Endocrinol Metab. 2006 ; 291 (2). E381 - E387
98. Breen L, Phillips SM. Skeletal muscle protein metabolism in the elderly: interventions to counteract the "anabolic resistance" of ageing. Nutr Metab. 2011 ; 8: 68
99. Boirie Y. Physiopathological mechanism of sarcopenia. J Nutr Health Aging. 2009 ; 13 (8). 717-723
100. Krawiec BJ, Frost RA, Vary TC, Jefferson LS, Lang CH. Hindlimb casting decreases muscle mass in part by proteasome-dependent proteolysis but independent of protein synthesis. Am J Physiol Endocrinol Metab. 2005 ; 289 (6). E969 - E980
101. Maki T, Yamamoto D, Nakanishi S, et al. Branched-chain amino acids reduce hindlimb suspension-induced muscle atrophy and protein levels of atrogin-1 and MuRF1 in rats. Nutr Res. 2012 ; 32 (9). 676-683
102. Baptista IL, Leal ML, Artioli GG, et al. Leucine attenuates skeletal muscle wasting via inhibition of ubiquitin ligases. Muscle Nerve. 2010 ; 41 (6). 800-808
103. Casperson SL, Sheffield-Moore M, Hewlings SJ, Paddon-Jones D. Leucine supplementation chronically improves muscle protein synthesis in older adults consuming the RDA for protein. Clin Nutr. 2012 ; 31 (4). 512-519
104. Yarandi SS, Zhao VM, Hebbar G, Ziegler TR. Amino acid composition in parenteral nutrition: what is the evidence?. Curr Opin Clin Nutr Metab Care. 2011 ; 14 (1). 75-82
105. De Bandt J-P, Cynober L. Therapeutic use of branched-chain amino acids in burn, trauma, and sepsis. J Nutr. 2006 ; 136 (1). 308S - 313S
106. Munoz KA, Satarug S, Tischler ME. Time course of the response of myofibrillar and sarcoplasmic protein metabolism to unweighting of the soleus muscle. Metabolism. 1993 ; 42 (8). 1006-1012
107. De Boer MD, Selby A, Atherton P, et al. The temporal responses of protein synthesis, gene expression and cell signalling in human quadriceps muscle and patellar tendon to disuse. J Physiol. 2007 ; 585 (pt 1). 241-251
108. Glover EI, Phillips SM, Oates BR, et al. Immobilization induces anabolic resistance in human myofibrillar protein synthesis with low and high dose amino acid infusion. J Physiol. 2008 ; 586 (pt 24). 6049-6061
109. Drummond MJ, Dickinson JM, Fry CS, et al. Bed rest impairs skeletal muscle amino acid transporter expression, mTORC1 signaling, and protein synthesis in response to essential amino acids in older adults. Am J Physiol Endocrinol Metab. 2012 ; 302 (9). E1113 - E1122
110. Breen L, Stokes KA, Churchward-Venne TA, et al. Two weeks of reduced activity decreases leg lean mass and induces "anabolic resistance" of myofibrillar protein synthesis in healthy elderly. J Clin Endocrinol Metab. 2013 ; 98 (6). 2604-2612
111. Coutinho EL, Gomes ARS, França CN, Oishi J, Salvini TF. Effect of passive stretching on the immobilized soleus muscle fiber morphology. Braz J Med Biol. 2004 ; 37 (12). 1853-1861
112. Griffiths RD, Palmer TE, Helliwell T, MacLennan P, MacMillan RR. Effect of passive stretching on the wasting of muscle in the critically ill. Nutrition. 1995 ; 11 (5). 428-432
113. Gibson JN, Smith K, Rennie MJ. Prevention of disuse muscle atrophy by means of electrical stimulation: maintenance of protein synthesis. Lancet. 1988 ; 2 (8614). 767-770
114. Wall BT, Dirks ML, Verdijk LB, et al. Neuromuscular electrical stimulation increases muscle protein synthesis in elderly type 2 diabetic men. Am J Physiol Endocrinol Metab. 2012 ; 303 (5). E614 - E623
115. Dirks ML, Wall BT, Snijders T, Ottenbros CLP, Verdijk LB, van Loon LJC. Neuromuscular electrical stimulation prevents muscle disuse atrophy during leg immobilization in humans. Acta Physiol (Oxf). 2014 ; 210 (3). 628-641
116. Hirose T, Shiozaki T, Shimizu K, et al. The effect of electrical muscle stimulation on the prevention of disuse muscle atrophy in patients with consciousness disturbance in the intensive care unit. J Crit Care. 2013 ; 28 (4). 536.e1-7
117. Vivodtzev I, Debigaré R, Gagnon P, et al. Functional and muscular effects of neuromuscular electrical stimulation in patients with severe COPD: a randomized clinical trial. Chest. 2012 ; 141 (3). 716-725
118. Gosselink R, Bott J, Johnson M, et al. Physiotherapy for adult patients with critical illness: recommendations of the European Respiratory Society and European Society of Intensive Care Medicine Task Force on Physiotherapy for Critically Ill Patients. Intensive Care Med. 2008 ; 34 (7). 1188-1199
119. Cruz-Jentoft AJ, Baeyens JP, Bauer JM, et al. Sarcopenia: European consensus on definition and diagnosis: report of the European Working Group on Sarcopenia in Older People. Age Ageing. 2010 ; 39 (4). 412-423
120. Evans WJ, Paolisso G, Abbatecola AM, et al. Frailty and muscle metabolism dysregulation in the elderly. Biogerontology. 2010 ; 11 (5). 527-536
121. Fried LP, Tangen CM, Walston J, et al. Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci. 2001 ; 56 (3). M146 - M156
122. Lipshutz AKM, Gropper MA. Acquired neuromuscular weakness and early mobilization in the intensive care unit. Anesthesiology. 2013 ; 118 (1). 202-215
123. Mitchell WK, Williams J, Atherton P, Larvin M, Lund J, Narici M. Sarcopenia, dynapenia, and the impact of advancing age on human skeletal muscle size and strength; a quantitative review. Front Physiol. 2012 ; 3: 260
124. Short KR, Bigelow ML, Kahl J, et al. Decline in skeletal muscle mitochondrial function with aging in humans. Proc Natl Acad Sci U S A. 2005 ; 102 (15). 5618-5623